AHR241220P25000
- 0.10
- 0.000.00%
American Healthcare REIT Newsroom
BofA Securities Maintains American Healthcare REIT(AHR.US) With Buy Rating, Announces Target Price $36
RBC Raises Price Target on American Healthcare REIT to $30 From $28, Keeps Outperform Rating
American Healthcares Analyst Ratings
Truist Financial Maintains American Healthcare REIT(AHR.US) With Buy Rating, Announces Target Price $29
JMP Securities Maintains American Healthcare REIT(AHR.US) With Buy Rating, Maintains Target Price $30
Colliers Securities Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $30
American Healthcare REIT, Inc. Receives Buy Rating From Barry Oxford Due to Strong Financial Performance and Strategic Acquisitions
Truist Financial Maintains American Healthcare REIT(AHR.US) With Buy Rating
Morgan Stanley Maintains American Healthcare REIT(AHR.US) With Buy Rating, Maintains Target Price $27
Morgan Stanley Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $27
Morgan Stanley Raises Price Target on American Healthcare REIT to $27 From $22, Keeps Overweight Rating
BofA Securities Maintains American Healthcare REIT(AHR.US) With Buy Rating
Analysts Are Bullish on Top NA Stocks: American Healthcare REIT, Inc. (AHR), Amer Sports, Inc. (AS)
Truist Financial Maintains American Healthcare REIT(AHR.US) With Buy Rating, Maintains Target Price $27
BofA Securities Maintains American Healthcare REIT(AHR.US) With Buy Rating, Announces Target Price $31
A Quick Look at Today's Ratings for American Healthcare REIT(AHR.US), With a Forecast Between $27 to $30
A Quick Look at Today's Ratings for American Healthcare REIT(AHR.US), With a Forecast Between $27 to $30
Buy Rating Affirmed for American Healthcare REIT on Strong Growth and Strategic Acquisitions
American Healthcare REIT Is Maintained at Market Outperform by JMP Securities
American Healthcares Analyst Ratings